On 25 to 28 October, the Korean Ginseng Society held the 13th International Ginseng Symposium.
Korean ginseng (Panax ginseng) has been used for various treatments for about 2,000 years. Based on numerous research results related to ginseng and red ginseng, the Ministry of Food and Drug Safety of Korea has officially recognised 6 major effects and these include immunity enhancement, overcoming fatigue, improvement of memory as well as blood circulation.
During the symposium, the results were announced, such as ginseng’s immunity against the infection of COVID 19 (professor Seo Sang-hee’s team from Chungnam National University, South Korea) and the effect of red ginseng on the inhibition of liver damage caused by arsenic exposure (Professor S.M. Kamruzzaman’s team in Bangladesh).
Professor Hyuk-Young Kwon’s team at Soonchunhyang University announced the inhibitory effect of ginsenoside Rd on sarcopenia, while Professor Narayan’s team at the University of Michigan in the US shown that administration of red ginseng in animal testing (mice) is safer and cause lesser damage to intestinal microbial diversity as compared to administration of antibiotics.
The results clearly shown the beneficial effects of ginseng and its possible applications in food and beverage products as well as in nutraceuticals.
